Genetically Engineered Insulin may CAUSE Diabetes Type 1 in Type 2 Diabetics

GE insulin diabetes

GE insulin diabetesJust when you think GMO crops have caused enough damage as possible, there’s a new study proving their munificence to a deeper level. A new study shows that GE-created synthetic insulin could actually cause Diabetes Type 1 in Type 2 diabetics. Thank you biotech industry for creating a potentially new way to get diabetes.

The study, published in the Journal of Clinical Endocrinology & Metabolism and titled “Insulin administration may trigger type 1 diabetes in Japanese type 2 diabetes patients with type 1 diabetes high-risk HLA class II and the insulin gene VNTR genotype,” is posing a possible explanation for why insulin treatment may accelerate morbidity and mortality in Type 2 diabetics.

The research showed that administering genetically susceptible Type 2 diabetes patients with recombinant insulin can trigger their bodies to target their own insulin, producing cells for autoimmune destruction and effectively producing ‘double diabetes’: Type 1 and Type 2, as a result.

Recombinant refers to anything that is inserted with foreign DNA (molecular cloning or genetic alteration) to make a new sequence. Insulin is no different. Our bodies already make their own natural insulin, but in diabetes Type 2 patients, their pancreatic secretions are not sufficient to make enough insulin and glucagon, and therefore they end up taking insulin to balance their sugar levels.

The Study

The latest study pointing to GMO insulin as the culprit in creating diabetes Type 1 took 6 patients (4 men and 2 women) in Japan with diabetes Type 2, all whom had not previously received insulin therapy for their disease, nor had markers for autoantibodies to their own body’s insulin in their blood.

All patients were found to have the Type 1 diabetes susceptibility gene known as Type 1 diabetes high risk HLA class II (IDDM1), considered a key factor in indicating whether someone develops diabetes Type 1. Insulin gene VNTR genotype (IDDM2) is believed to determine largely if someone develops diabetes Type 2.

The participants were given recombinant insulin to control blood glucose deterioration…

“and their own insulin producing beta cells – as measured by declining C-peptide levels (a marker for the production of natural insulin) – decreased insulin production to a deficiency levels commonly found in type 1 diabetes patients.

The average time it took for the patients to develop full blown type 1 diabetes was 7.7 months, with one patient developing the condition within 1.1 months, and further test revealed that antibodies against their own pancreatic islet cells (the cells responsible for producing insulin were destroyed.”

Normally, insulin is derived from animals to treat diabetes tType 2 patients, but genetically engineered insulin is now being considered for use in many vaccines, “intended to induce a ‘tolerogenic immune response’ and therefore ameliorate autoimmune type 1 diabetes.” GMO insulin is not the same, and it turns out it is just as vile as the crops themselves, causing the human system to attack itself.  You can read the details at JCEM, where the study was published.